Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review

Author:

Lu Ji,Xu Zhihui,Jiang Fengming,Wang Yan,Hou Yuchuan,Wang Chunxi,Chen Qihui

Abstract

Abstract Clear cell carcinoma of the bladder is a rare tumor of the bladder. There are few reports available on this rare disease, and no cases with recurrence were reported. Here we present a case of 68-year-old woman with primary clear cell carcinoma of the bladder, who underwent repeat TUR-BT and tumor recurrence. We also reviewed the previous treatments and prognoses in previous case reports and evaluate the proper treatment for this disease. Once the diagnosis is determined, the radical surgery should be recommended. The recurrence is not prevented based on post-TUR intravesical therapy.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Reference24 articles.

1. Ploeg M, Aben KK, Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol. 2009, 27 (3): 289-93. 10.1007/s00345-009-0383-3.

2. Fleshner NE, Herr HW, Stewart AK, Murphy GP, Mettlin C, Menck HR: The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1996, 78 (7): 1505-13. 10.1002/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3.

3. Kantor AF, Hartge P, Hoover RN, Fraumeni JF: Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res. 1988, 48 (13): 3853-5.

4. Eble JN, Epstein JI, Seternhenn IA: World Health Organization Classification of Tumours Pathology and Genetics, Tumours of the Urinary System and Male Genital track. 2004, Lyon: IARC Press, 128-132.

5. Dow JA, Young JD: Mesonephric adenocarcinoma of the bladder. J Urol. 1968, 100 (4): 466-9.

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3